147 related articles for article (PubMed ID: 22185198)
1. Association analysis identifies ZNF750 regulatory variants in psoriasis.
Birnbaum RY; Hayashi G; Cohen I; Poon A; Chen H; Lam ET; Kwok PY; Birk OS; Liao W
BMC Med Genet; 2011 Dec; 12():167. PubMed ID: 22185198
[TBL] [Abstract][Full Text] [Related]
2. A promoter sequence variant of ZNF750 is linked with familial psoriasis.
Yang CF; Hwu WL; Yang LC; Chung WH; Chien YH; Hung CF; Chen HC; Tsai PJ; Fann CS; Liao F; Chen YT
J Invest Dermatol; 2008 Jul; 128(7):1662-8. PubMed ID: 18256691
[TBL] [Abstract][Full Text] [Related]
3. Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk.
Dębniak T; Soczawa E; Boer M; Różewicka-Czabańska M; Wiśniewska J; Serrano-Fernandez P; Mirecka A; Paszkowska-Szczur K; Lubinski J; Krysztoforska L; Adamski Z; Maleszka R
Arch Dermatol Res; 2014 Apr; 306(3):231-8. PubMed ID: 24005976
[TBL] [Abstract][Full Text] [Related]
4. Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.
Birnbaum RY; Zvulunov A; Hallel-Halevy D; Cagnano E; Finer G; Ofir R; Geiger D; Silberstein E; Feferman Y; Birk OS
Nat Genet; 2006 Jul; 38(7):749-51. PubMed ID: 16751772
[TBL] [Abstract][Full Text] [Related]
5. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
[No Abstract] [Full Text] [Related]
6. Variation in the FABP2 promoter affects gene expression: implications for prior association studies.
Formanack ML; Baier LJ
Diabetologia; 2004 Feb; 47(2):349-51. PubMed ID: 14666368
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells.
Nikamo P; Cheuk S; Lysell J; Enerbäck C; Bergh K; Xu Landén N; Eidsmo L; Ståhle M
J Invest Dermatol; 2014 Jun; 134(6):1535-1541. PubMed ID: 24390134
[TBL] [Abstract][Full Text] [Related]
8. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene.
Takane H; Kobayashi D; Hirota T; Kigawa J; Terakawa N; Otsubo K; Ieiri I
J Pharmacol Exp Ther; 2004 Dec; 311(3):1179-87. PubMed ID: 15280437
[TBL] [Abstract][Full Text] [Related]
9. ZNF750 is expressed in differentiated keratinocytes and regulates epidermal late differentiation genes.
Cohen I; Birnbaum RY; Leibson K; Taube R; Sivan S; Birk OS
PLoS One; 2012; 7(8):e42628. PubMed ID: 22936986
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein-C promoter variants associated with neonatal respiratory distress syndrome reduce transcription.
Wambach JA; Yang P; Wegner DJ; An P; Hackett BP; Cole FS; Hamvas A
Pediatr Res; 2010 Sep; 68(3):216-20. PubMed ID: 20539253
[TBL] [Abstract][Full Text] [Related]
11. Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease.
Prescott NJ; Dominy KM; Kubo M; Lewis CM; Fisher SA; Redon R; Huang N; Stranger BE; Blaszczyk K; Hudspith B; Parkes G; Hosono N; Yamazaki K; Onnie CM; Forbes A; Dermitzakis ET; Nakamura Y; Mansfield JC; Sanderson J; Hurles ME; Roberts RG; Mathew CG
Hum Mol Genet; 2010 May; 19(9):1828-39. PubMed ID: 20106866
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
13. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
[No Abstract] [Full Text] [Related]
14. Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients.
Price JA; Fossey SC; Sale MM; Brewer CS; Freedman BI; Wuerth JP; Bowden DW
Diabetologia; 2000 Mar; 43(3):364-72. PubMed ID: 10768098
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the promoter region of human BCL-6 gene.
Ohashi K; Miki T; Hirosawa S; Aoki N
Biochem Biophys Res Commun; 1995 Sep; 214(2):461-7. PubMed ID: 7677752
[TBL] [Abstract][Full Text] [Related]
16. ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes.
Boxer LD; Barajas B; Tao S; Zhang J; Khavari PA
Genes Dev; 2014 Sep; 28(18):2013-26. PubMed ID: 25228645
[TBL] [Abstract][Full Text] [Related]
17. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation.
Sen GL; Boxer LD; Webster DE; Bussat RT; Qu K; Zarnegar BJ; Johnston D; Siprashvili Z; Khavari PA
Dev Cell; 2012 Mar; 22(3):669-77. PubMed ID: 22364861
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the TATA-less promoter from the human GFI1 proto-oncogene.
Liu S; Cowell JK
Ann Hum Genet; 2000 Jan; 64(Pt 1):83-6. PubMed ID: 11246463
[TBL] [Abstract][Full Text] [Related]
20. RNA sequencing analysis of the CAL-27 cell response to over-expressed ZNF750 gene revealed an extensive regulation on cell cycle.
Liu X; Yang Y; Xu C; Yang H; Chen S; Chen H
Biomed Pharmacother; 2019 Oct; 118():109377. PubMed ID: 31545271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
